0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Lana A. Castellucci, MD; Chris Cameron, MSc; Grégoire Le Gal, MD, PhD; et al.
JAMA. 2014;312(11):1122-1135. doi:10.1001/jama.2014.10538.
Includes: Supplemental Content

JAMA Patient Page |  FREE
Jill Jin, MD, MPH
JAMA. 2014;312(11):1167. doi:10.1001/jama.2014.2078.
Includes: Supplemental Content

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2014;312(9):955-957. doi:10.1001/jama.2014.10644.

Review | 
Anita Kohli, MD, MS; Ashton Shaffer, BA; Amy Sherman, MD; et al.
JAMA. 2014;312(6):631-640. doi:10.1001/jama.2014.7085.
Includes: CME, Supplemental Content

Original Investigation | 
Wen-Hung Chung, MD, PhD; Wan-Chun Chang, MS; Yun-Shien Lee, PhD; et al.
JAMA. 2014;312(5):525-534. doi:10.1001/jama.2014.7859.
Includes: Supplemental Content

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(4):328. doi:10.1001/jama.2014.8885.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(4):328. doi:10.1001/jama.2014.9118.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(4):328. doi:10.1001/jama.2014.9120.

Clinical Trials Update | 
Anita Slomski
JAMA. 2014;312(4):327. doi:10.1001/jama.2014.9150.

Research Letter | 
Nikolai Madrid Scheller, MB; Björn Pasternak, MD, PhD; Henrik Svanström, MSc; et al.
JAMA. 2014;312(2):187-188. doi:10.1001/jama.2014.2198.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Neurology
Original Investigation  | 
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases
Annette Langer-Gould, MD, PhD; Lei Qian, PhD; Sara Y. Tartof, PhD; et al.
JAMA Ophthalmology
Brief Report  | 
Risk for Uveitis With Oral Moxifloxacin:  A Comparative Safety Study
Brennan Eadie, MD, PhD; Mahyar Etminan, PharmD, MSc; Frederick S. Mikelberg, MD, FRCSC
JAMA Ophthalmology
Invited Commentary  | 
We Need to Be Better Prepared for Hydroxychloroquine Retinopathy
Hendrik P. N. Scholl, MD, MA; Syed Mahmood Ali Shah, MBBS
JAMA Ophthalmology
Original Investigation  | 
The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy
Ronald B. Melles, MD; Michael F. Marmor, MD